FBXO32 and adenocarcinoma: As summarized in Figure 6, C26 adenocarcinoma led to significant cancer cachexia accompanied by muscle degeneration with disturbed muscle regeneration, high TNF-α and IL-6 levels, MAPK activation leading to increased atrogin-1/MuRF-1 levels, and lipolysis.